In view of the close similarity between bovine leukemia virus (BLV) an
d human T-cell leukemia virus type I (HTLV-I) we investigated the poss
ibility of developing specific inhibitors of the proteases of these re
troviruses using the purified enzyme from BLV. We tested the ability o
f this protease to specifically cleave various short oligopeptide subs
trates containing cleavage sites of BLV and HTLV-I proteases, as well
as a recombinant BLV Gag precursor. The best substrate, a synthetic de
capeptide bearing the natural cleavage site between the matrix and the
capsid proteins of BLV Gag precursor polyprotein, was used to develop
an inhibition assay. We determined the relative inhibitory effect of
synthetic Gag precursor-like peptides in which the cleavable site was
replaced by a non-hydrolyzable moiety. The encouraging inhibitory effe
ct of these compounds indicates that potent non-peptidic inhibitors fo
r retroviral proteases are not unattainable.